EXHIBIT 21.1
SUBSIDIARIES OF FORTRESS BIOTECH, INC.
Subsidiaries of Fortress Biotech, Inc. at December 31, 2019, with jurisdiction of incorporation or formation:
| • | Aevitas Therapeutics, Inc. (Delaware) | |
| • | Avenue Therapeutics, Inc. (Delaware) | |
| • | Baergic Bio, Inc. (Delaware) | |
| • | Caelum Biosciences, Inc. (Delaware), formerly FBIO Acquisition Corp. II | |
| • | Cellvation, Inc. (Delaware), formerly FBIO Acquisition Corp. I | |
| • | Checkpoint Therapeutics, Inc. (Delaware) | |
| • | Cyprium Therapeutics, Inc. (Delaware) | |
| • | Helocyte, Inc. (Delaware), formerly DiaVax Biosciences, Inc. | |
| Hepla Sciences, Inc. (Delaware), formerly FBIO Acquisition Corp. IV | ||
| • | Journey Medical Corporation (Delaware) | |
| • | Mustang Bio, Inc. (Delaware) | |
| Oncogenuity, Inc. (Delaware), formerly FBIO Acquisition Corp. VI | ||
| • | CB Securities Corporation (Massachusetts) | |
| • | Coronado SO Co. (Delaware) | |
| • | Escala Therapeutics, Inc., formerly Altamira Biosciences, Inc. (Delaware) | |
| • | FBIO Acquisition Corps. VI – XIV (Delaware) | |
| • | Fortress Biotech, China, Inc. | |
| • | Innmune Limited (United Kingdom) | |
| • | Tamid Bio, Inc. (Delaware) | |